SOURCES SOUGHT
A -- Medication Measures for Part D
- Notice Date
- 7/13/2005
- Notice Type
- Sources Sought
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, Centers for Medicare & Medicaid Services, formerly known as the Health Care Financing Administration, Acquisition and Grants Group, 7500 Security Blvd. C2-21-15, Central Building, Baltimore, MD, 21244-1850
- ZIP Code
- 21244-1850
- Solicitation Number
- CMS-05-MM-RFP-LMG
- Description
- The Centers for Medicare & Medicaid Services (CMS) intends to issue a Request for Proposal (RFP) to develop Part D Medication Measures at the Prescription Drug Plans (PDPs) and/or Medicare Advantage Prescription Drug Plans (MA-PDPs), pharmacy and/or physician level that can be used for quality improvement and intervention, evaluation and monitoring of the clinical and economic impact of the Part D benefit, and for public reporting purposes. The measures (to the extent feasible) shall be based on the Institute of Medicine?s (IOMs) domains of safety, effectiveness, patient-centered, timeliness, efficiency and equitability. A limited number of measures shall be developed that focus on specific categories/subcategories. The measures shall be limited to approximately two specific disease states and up to 10 specific drugs or drug classes. The categories/subcategories are: 1. Prescribing Use of avoidable drugs in elderly; Generic prescribing ratios; Use of selected medications within certain therapeutic categories; 2. Disease-specific therapy Drug-disease interaction; Therapeutic monitoring associated with specific drug utilization; 3. Appropriateness of Therapy Measures?appropriate prescribing and drug regimen for specified disease states such as: Cardiovascular (Heart Failure, Coronary Artery Disease/Acute Myocardial Infarction, Artial Fibrillation, and Hypertension); Second disease state will be determined by CMS; 4. Cost effective drug utilization management/economic impact; 5. Quality assurance to reduce medication errors and adverse drug interactions and improve medication use; and 6. Controlling fraud, abuse and waste. Interested sources must possess an existing license and expertise in the use of Medispan, First Data Bank or other comparable system. The period of performance is 12 months. The North American Industry Classification System (NAICS) Code is 541710. RFP Number CMS-05-MM-RFP-LMG is anticipated to be released 15 days from the date of publication of this notice and will be made available at www.fedbizopps.gov.
- Record
- SN00846077-W 20050715/050713211848 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |